CINECA IRIS Institutional Research Information System

Health-related quality of life from the MM-003 trial of pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone in relapsed and/or refractory multiple myeloma

PALUMBO, Antonio;
2015-01-01
2015
HAEMATOLOGICA
100
2
e63
e67
Pomalidomide; multiple myeloma; quality of life; Antineoplastic Combined Chemotherapy Protocols; Cross-Sectional Studies; Dexamethasone; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Longitudinal Studies; Male; Middle Aged; Multiple Myeloma; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Thalidomide; Quality of Life
Song, Kevin W; Dimopoulos, Meletios A; Weisel, Katja C; Moreau, Philippe; Palumbo, Antonio; Belch, Andrew; Schey, Stephen; Sonneveld, Pieter; Sternas, Lars; Yu, Xin; Amatya, Ramesh; Monzini, Mara S; Zaki, Mohamed; Jacques, Christian; San Miguel, Jesus
03A-Articolo su Rivista
File in questo prodotto:
File Dimensione Formato  
Haematologica. 2015 Feb 100(2) e63-7.pdf

Accesso aperto

Tipo di file: PDF EDITORIALE
Dimensione 485.57 kB
Formato Adobe PDF
Visualizza/Apri
485.57 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/1527141
Citazioni
  • ???jsp.display-item.citation.pmc??? 7
  • Scopus 23
  • ???jsp.display-item.citation.isi??? 21
social impact